First biological evaluation of developed 3-benzyloxyfluorenes as novel class of MDR modulators. | Eur J Med Chem;45(6): 2683-8, 2010 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

First biological evaluation of developed 3-benzyloxyfluorenes as novel class of MDR modulators.

Krug, Martin; Voigt, Burkhardt; Baumert, Christiane; Lüpken, Ralf; Molnár, Joséf; Hilgeroth, Andreas.

Affiliation

Krug M; Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Wolfgang-Langenbeck Str. 4, D-06120 Halle, Germany.

Eur J Med Chem ; 45(6): 2683-8, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20207048

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Multiple / Drug Discovery / Fluorenes Limits: Animals Language: En Journal: Eur J Med Chem Year: 2010 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Multiple / Drug Discovery / Fluorenes Limits: Animals Language: En Journal: Eur J Med Chem Year: 2010 Document type: Article Affiliation country: